The Role of Speckle Tracking Echocardiography in the Evaluation of Common Inherited Cardiomyopathies in Children and Adolescents: A Systematic Review by Dorobantu, DM et al.
diagnostics
Systematic Review
The Role of Speckle Tracking Echocardiography in the
Evaluation of Common Inherited Cardiomyopathies in
Children and Adolescents: A Systematic Review
Dan M. Dorobantu 1,2 , Curtis A. Wadey 1 , Nurul H. Amir 2,3, A. Graham Stuart 2,4 , Craig A. Williams 1,*
and Guido E. Pieles 2,4,5


Citation: Dorobantu, D.M.; Wadey,
C.A.; Amir, N.H.; Stuart, A.G.;
Williams, C.A.; Pieles, G.E. The Role
of Speckle Tracking
Echocardiography in the Evaluation
of Common Inherited
Cardiomyopathies in Children and
Adolescents: A Systematic Review.
Diagnostics 2021, 11, 635. https://
doi.org/10.3390/diagnostics11040635
Academic Editor: Gaetano Nucifora
Received: 23 February 2021
Accepted: 12 March 2021
Published: 1 April 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 Children’s Health and Exercise Research Centre (CHERC), University of Exeter, Exeter EX1 1TX, UK;
dd389@exeter.ac.uk (D.M.D.); cw694@exeter.ac.uk (C.A.W.)
2 Population Health Sciences Department, University of Bristol, Bristol BS8 2PS, UK;
nurul.amir@bristol.ac.uk (N.H.A.); Graham.Stuart@nhs.net (A.G.S.); Guido.Pieles@bristol.ac.uk (G.E.P.)
3 Faculty of Sport Science and Recreation, Universiti Teknologi MARA, Perlis Branch, Arau Campus,
Perlis 40450, Malaysia
4 National Institute for Health Research (NIHR) Cardiovascular Biomedical Research Centre,
Congenital Heart Unit,Bristol Heart Institute, Bristol BS2 8ED, UK
5 Institute of Sport, Exercise and Health, University College London, London W1T 7HA, UK
* Correspondence: c.a.williams@exeter.ac.uk
Abstract: Speckle tracking echocardiography (STE) has gained importance in the evaluation of adult
inherited cardiomyopathies, but its utility in children is not well characterized. We conducted a
systematic review to evaluate the role of STE in pediatric inherited cardiomyopathies. PubMed,
EMBASE, Web of Science, Scopus, CENTRAL and CINAHL databases were searched up to May 2020,
for terms related to inherited cardiomyopathies and STE. Included were dilated cardiomyopathy
(DCM), hypertrophic cardiomyopathy (HCM), left ventricular non-compaction (LVNC) and arrhyth-
mogenic cardiomyopathy (ACM). A total of 14 cohorts were identified, of which six were in DCM,
four in HCM, three in LVNC and one in ACM. The most commonly reported STE measurements
were left ventricular longitudinal strain (Sl), circumferential strain (Sc), radial strain (Sr) and rota-
tion/torsion/twist. Sl, Sc and were abnormal in all DCM and LVNC cohorts, but not in all HCM.
Apical rotation and twist/torsion were increased in HCM, and decreased in LVNC. Abnormal STE
parameters were reported even in cohorts with normal non-STE systolic/diastolic measurements.
STE in childhood cardiomyopathies can detect early changes which may not be associated with
changes in cardiac function detectable by non-STE methods. Longitudinal and circumferential strain
should be introduced in the cardiomyopathy echocardiography protocol, reflecting current practice
in adults.
Keywords: speckle tracking echocardiography; pediatric inherited cardiomyopathy; dilated car-
diomyopathy; hypertrophic cardiomyopathy; left ventricular non-compaction; arrhythmogenic car-
diomyopathy
1. Introduction
The publication of recent registry-based reports has led to an increasing interest in
the pediatric inherited cardiomyopathies, including hypertrophic cardiomyopathy (HCM),
dilated cardiomyopathy (DCM), left ventricle non-compaction cardiomyopathy (LVNC)
and arrhythmogenic cardiomyopathy (ACM) [1–3]. Although rare [1–3], they carry a
significant mortality and morbidity burden: DCM is the main indication for pediatric heart
transplant [1]; 7% of older children or adolescents with HCM died or received a heart
transplant [2]; isolated LVNC, diagnosed in late childhood or adolescence, has 6% mortality
at 5 years [3]; pediatric ACM has been associated with a high prevalence of life threatening
arrhythmia at first presentation, compared to adults [4].
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Diagnosis and follow-up of cardiomyopathy patients can be complicated by hetero-
geneity in clinical presentation and etiology, as well as overlap with acquired causes, such
as myocarditis, or normal variants, such as athletes. Two dimensional speckle tracking
echocardiography (STE) is used routinely in the management of adult cardiomyopathies
and has been associated with clinical outcomes in HCM [5], DCM [6], LVNC [7] and
ACM [8], aiding screening and early diagnosis [9–13]. Despite overwhelming data from
the adult cardiomyopathy practice, STE has only recently started to gain importance on the
pediatric side.
The aim of this study is to conduct a systematic review and meta-analysis of studies
reporting STE measurements in pediatric inherited cardiomyopathies. The objectives of
the review included understanding this technique’s current use in clinical practice, as
compared to conventional echocardiographic techniques, and how its role in this field
could be expanded in the future.
2. Materials and Methods
2.1. Study Design and Aims
This study was designed according to the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines [14]. The protocol was submitted to
PROSPERO (CRD42020170433) during abstract screening. The primary aim of the study
was to evaluate the role of STE in the diagnosis and follow-up of common inherited
cardiomyopathies presenting in later childhood, beyond infancy. The secondary aim was
to compare STE with conventional techniques in the same setting.
2.2. Study Eligibility
Inclusion criteria were: (1) Children or adolescents (mean or median age < 18 years);
(2) Condition of interest: HCM, DCM, LVNC, ACM; (3) Echocardiography at rest with any
STE measurement; (4) full text paper published in a peer-reviewed journal.
Exclusion criteria were: (1) Mean/median age under 2 years (or predominantly
“neonate”, “infant” or “toddler”); (2) mean/median age over 20 years; (3) other cardiomy-
opathies (e.g., muscular dystrophies, mitochondrial diseases, amyloidosis, degenerative,
metabolic or infectious cardiomyopathies, oncological treatment related disease, congen-
ital heart disease, myocarditis, arrhythmic); (4) critically ill patients (New York Heart
Association/Ross functional class IV, on inotrope support, on ventricular assist devices or
circulatory assist); (5) MRI derived strain imaging; (6) Tissue Doppler strain; (7) 3D/4D
STE studies, with no 2D STE data; (8) conference abstracts without full text paper available.
For studies with a mean/median reported age between 2–6 years or 18–20 years, those
where the reported age distribution corresponded to mostly infants (<1 year)/toddlers
(<3 years) or adults, respectively (>18 years), have been excluded, through consensus of
the team. If mixed cardiomyopathies are reported, the study was excluded if more than
10% of the study population had another diagnosis than the four stated in the inclusion
criteria. There were no language restrictions.
2.3. Database Search
PubMed, EMBASE, Web of Science, Scopus, Cochrane CENTRAL and EBSCO CINAHL
databases were searched from inception to May 2020. The search strategy included the
combined terms relating to the common inherited cardiomyopathies (i.e., HCM, DCM,
LVNC, ACM or “cardiomyopathy”), pediatric population, echocardiography and speckle
tracking imaging. The full search strategy, pre-published on PROSPERO, is available in
Supplementary Materials (Search Strategy).
2.4. Study Selection and Data Extraction
Title and abstract and full text screening were performed using the Covidence® plat-
form (Veritas Health Innovation Ltd, Melbourne, Australia), independently, by two re-
viewers (D.M.D. and C.W.). Data extraction was conducted independently by D.M.D. and
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C.W. which included study and methodology description, patient/control group demo-
graphics, STE and conventional echocardiography measurements, which were checked for
discrepancies. In all of the steps above, a third reviewer (G.P.) arbitrated disagreements,
and any discrepancies were resolved through team consensus. Corresponding authors
were contacted and asked for any non-reported outcome data for their respective cohorts,
relevant to this analysis.
2.5. Risk of Bias Assessment
Risk of bias was assessed independently by D.M.D. and C.W. using the Newcastle-
Ottawa scale for case control studies [15]. Risk of bias assessment was done for 13 papers,
since two studies [16,17] presented the same cohort. Studies were also graded into “low”,
“medium” and “high” risk of bias, taking into consideration the Newcastle-Ottawa scales,
through team consensus. More detail on the risk of bias assessment can be found in
Supplementary Materials.
Publication bias was assessed visually by funnel plots of standardized mean difference
(SMD) and standard error of SMD, and using the Egger test, acknowledging that this
method could result in over-estimation of risk of publication bias when SMD is used [18].
2.6. STE and Conventional Echocardiographic Measurements
For the purpose of plotting and analysis, STE measurements were grouped as follows:
longitudinal strain—Sl, including apical four chamber (A4C) and global longitudinal
strain (GLS); circumferential strain—Sc, including basal, mid and apical circumferential
strain; radial strain—Sr including basal, mid and apical radial strain; twist or torsion;
basal rotation; and apical rotation. The main non STE measurements were left ventricular
ejection fraction (LVEF), septal S’, E/A and E/E’ ratios. Details on all echocardiographic
data extracted are found in Supplementary Materials (Additional Methodological Data).
2.7. Statistical Analysis
Frequencies are given as numbers and percentages, continuous values as means and
standard deviation (SD). Numerical values extraction, transformation and calculation
of missing statistical parameters are detailed in Supplementary Materials (Additional
Methodological Data).
Data were summarized according to the Synthesis without meta-analysis (SWiM)
guidelines [19], and presented by cardiomyopathy type. Given the high heterogeneity of
the results, continuous variables were reported as range, or as individual data points, not
as means. Albatross plots were used to compare and summarize the effect size, sample size
and p values, due to the applicability in diversely reported studies [20]. Actual SMD values
are reported in tabular form (Tables S1 and S2), with SMD contours in the Albatross plots
assuming all studies have a 1:1 disease to control ratio, exclusively for in-between study
comparisons’ visual representation. Statistical analyses were conducted using STATA/SE
12 (StataCorp LP, College Station, TX, USA).
3. Results
After screening 949 papers, with 102 full text articles assessed for eligibility, a total
of 14 papers (14 cohorts) fulfilled the inclusion criteria and had no exclusion criteria
(Figure 1). One paper included both a DCM and a HCM cohort, and was considered as
two cohorts [21], while two papers reported different measurements in the same cohort at
two different times [16,17]. Thirteen were case control studies with healthy controls, one
had HCM with and without high risk genotype as participants/controls, and only one had
partial follow-up after baseline evaluation.
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Figure 1. PRISMA flowchart of screened, included and excluded studies.
3.1. Selected Studies
Characteristics of included studies and reported STE measurements are summarized
in Table 1. Of the 14 cohorts, six were in DCM, four in HCM, three in LVNC and 1 in ACM.
The number of participants ranged from 10–50, with a mean of 28 (10). Mean age ranged
from 4.5–15 years, and males accounted from 46–86% of samples.
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Most commonly reported non-STE cardiac systolic and diastolic function measure-
ments were LVEF (n = 14), septal S’ (n = 5), E/A ratio (n = 7) and E’/E’ ratio (n = 9),
summarized in Table S1.






Study Size, No. Mean Age, y (sd) Male, No. (%) STE
MeasurementsCardiomyopathy Controls Cardiomyopathy Controls Cardiomyopathy Controls
Dilated cardiomyopathy (DCM)
Jin et al. [22] Not specified 10 17 5.9 (4.6) 6 (4.2) 7 (70) 12 (70.5)





LVEDD > 2 SD
LVEF < 55% 24 16 10 (6) 10 (6) 11 (45.8) 4 (25) mid Sr
Labombarda
et al. [24]
LVEDD > 2 SD
LVEF < 50% 25 25 7.8 (4.9) 7.8 (4.9) 17 (68) 17 (68)
dyssynchrony
parameters
Agha et al. [25] Not specified 32 32 5.1 (4.4) 5.88 (3.92) 19 (59.4) 20 (62.5) LV GLS
Sabatino et al.
[21]
LVEDD > 2 SD
LVEF < 50% 44 45 5 (5.2) 10.4 (4.7) 21 (47.7) 18 (40) LV A4C Sl
Maher et al. [26] Not specified 50 50 4.5 (1.8) 4.6 (2) 29 (58) 27 (54) LV A4C Sl
Hypertrophic cardiomyopathy (HCM)







24 20 14.1 (5.5) 14.1 (5.5) 14 (58.3) 14 (70) rotationalmechanics



















40 45 10.9 (5.5) 10.4 (4.7) 24 (60) 18 (40) LV A4C Sl






25 0 6.1 (4.5) 19 (76) LV A4C Sl, basalSc, basal Sr
Left ventricular non-compaction (LVNC)
Ari et al. [30] Jenni [31] criteria 20 20 12.1 (3.3) 11.8 (3.1) 16 (80) 16 (80) LV A4C Sl, midSc























CMR criteria 23 47 11.3 (5.3) 11.1 (5.3) 12 (60) 24 (40)












38 35 15 (3) 13 (4) 26 (68.4) 29 (82.9) RV Sl
A4C, apical 4 chamber view; CMR, cardiac magnetic resonance; GLS, global longitudinal strain; LV, left ventricle; LVEDD, left ventricular
end-diastolic diameter; LVEF, left ventricular ejection fraction; RV, right ventricle; Sc, circumferential strain; Sl, longitudinal strain; Sr, radial
strain; STE, speckle tracking echocardiography.
3.2. Dilated Cardiomyopathy
Mean age in six DCM studies ranged from 4.5–10 years, male percentage from 48% to
70%. Figure 2A shows a summary of STE findings in these studies: there were less negative
Sl (−11% to −15% in 3 studies), Sr (−15.7% and −18.5% in 2 studies) and Sc (−9.5% in
one study); one study reported reduced twist (0.3◦ vs. 10.9◦), mostly due to reduced
apical rotation (0.9◦ vs. 5.9◦). An additional study (not shown in Figure 2A) reported
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only mechanical dyssynchrony measurements derived from STE, of which we mention
maximum Sl and Sr delays, both significantly higher in DCM. Mean differences, SMDs and
p values are detailed in Table S2. All DCM cohorts reported reduced LVEF (mean ranging
from 26.5% to 49.7%), with three reporting reduced septal S’, two reporting increased E/E’
ratio and thee reporting comparable E/A ratio (Figure 3A).
Figure 2. Albatross plot showing estimated standardized mean differences contours (curved lines), p values for difference
between inherited cardiomyopathy and controls (horizontal axis) and study sample size (vertical axis) of speckle tracking
measurements by cardiomyopathy type in (A). Dilated cardiomyopathy; (B). Hypertrophic cardiomyopathy (C). Left
ventricular non-compaction. Negative association–lower values (including more negative) associated with disease; positive
association–higher values (including less negative) associated with disease. A4C, apical four chamber view; GLS, global
longitudinal strain; rot, rotation; Sl, longitudinal strain; Sc, circumferential strain; Sr, radial strain.
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Figure 3. Albatross plot showing estimated standardized mean differences contours (curved lines), p values for difference
between inherited cardiomyopathies and controls (horizontal axis) and study sample size (vertical axis) of conventional
echocardiographic measurements by cardiomyopathy type in (A). Dilated cardiomyopathy; (B). Hypertrophic cardiomy-
opathy (C). Left ventricular non-compaction. Negative association–lower values (including more negative) associated with
disease; positive association–higher values (including less negative) associated with disease.
3.3. Hypertrophic Cardiomyopathy
Mean age in four HCM studies ranged from 6.1–14.1 years, male percentage from 60%
to 85%. Figure 2B shows a summary of STE reported findings in the HCM cohorts: Sl was
normal in one study (−21.3%) and less negative in two (−15.8% and −16.7%); Sc was
abnormal in one study (−17.5%) and normal in one study (−22.2%); two studies reported
rotational mechanics, showing increased twist, with more positive apical rotation (11.7◦ vs.
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5.3◦ and 13.9◦ vs. 8.8◦) and torsion, with more negative basal rotation (−8.7◦ vs. −4.9◦ and
2.8◦/mm vs. 1.9◦/mm), respectively. Mean differences, SMDs and p values are detailed in
Table S2. All studies included patients with normal or supra-normal LVEF (mean ranging
from 64–67.4%), one study reported normal septal S’ values, E/E’ was increased in one
study and normal in one study, while the E/A ratio was reported normal in two studies
(Figure 3B).
3.4. Left Ventricular Non-Compaction
Mean age in four LVNC studies ranged from 7.2–12.1 years, male percentage from 50%
to 80%. Sl ranged from −15.3% to 18% in four studies. All studies reported less negative
Sc (−18.1% to −19.1% for basal, −16.3% to −24.6% for mid and −14.9% to −20.6% for
apical). Sr was also reduced in two studies, for all three segments. Two studies reported
rotational mechanics, showing reduces twist (10◦ vs. 15.1◦ and 3.8◦ vs. 13.5◦ respectively),
both due to reduced apical rotation. Mean differences, SMDs and p values are detailed in
Table S2. All studies reported normal or mildly reduced LVEF (mean ranging from 54%
to 68.9%), one study reported normal septal S’ values, three studies reported normal or
mildly increased E/E’ values and one study reported normal E/A ratio (Figure 3C).
3.5. Arrhythmogenic Cardiomyopathy
Only one study reported STE measurements in children with ACM, with a mean age
of 15 years, 68% male. The main findings were a less negative RV Sl, both global (−21%
vs. −25%) and free wall (−19% vs. −24%), more markedly in the apical segments, despite
similar FAC, TAPSE and RV S’ values (Tables S1 and S2).
3.6. Risk of Bias Assessment
3.6.1. Publication Bias
Overall risk of publication bias for any measurement was low (Egger p value 0.08), as
presented in Figure 4. Risk of publication bias analysis was also repeated in subgroups by
cardiomyopathy and STE measurement types, and found no high risk of bias (all Egger
p values > 0.05).
Figure 4. Funnel plot of Standardized Mean Difference (SMD) and SMD standard error with pseudo 95% CI limits for all
study measurements, showing no significant asymmetry, which suggests low risk of publication bias. Eggert test p value
is 0.08.
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3.6.2. Study Methodology Bias
Most studies, 9/13, were graded as medium risk of bias, 3/13 as low risk and 1/13 as
high risk (Figure 5). The three studies with low risk either managed to perform a blinded
evaluation of STE images, clearly report a comparable proportion of patients/controls with
unusable STE images, or both. One study offers limited to no information on selection
of cases and controls, and scored no point in the “Selection” item of the scale. Studies
obtaining lower scores in the Selection item either failed to detail how the patients were
selected (i.e., consecutive or not) or, in one instance, did not use healthy controls. These
findings do not reflect poor study methodology or quality, but rather inherent limitations
of echocardiographic case-control studies, where consecutive case selection, community
controls and blinding of evaluation are not always feasible.
Figure 5. Newcastle Ottawa scale risk of bias evaluation results. Total maximum is 9 points, Selection is 3 points,
Comparability is 2 points and Exposure is 4 points. Semi qualitative subjective risk of bias grading is green for low risk,
orange for some concerns and red for high risk.
4. Discussion
This systematic review on the use of 2D STE in the main forms of pediatric inherited
cardiomyopathy, DCM, HCM, LVNC and ACM, revealed several important findings.
Firstly, only 14 studies were found (a single study in ACM), with high heterogeneity by
cardiomyopathy type and STE measurement. This observation is despite accumulating
evidence of the usefulness of STE in adult cardiomyopathy, both in early diagnosis [9–11,38]
and outcome prediction [5–8,39]. Secondly, changes in STE parameters were described
in pediatric cohorts where systolic or diastolic ventricular function were comparable
to the healthy controls, demonstrating there is added value of STE over conventional
echocardiography in the evaluation of children with cardiomyopathies.
When interpreted in the context of existing adult inherited cardiomyopathy data, the
findings of this systematic review support the use of measurement of STE systolic function
parameters in the evaluation of children. When expertise is available, rotational mechanics
parameters, in addition to conventional echocardiographic techniques, could offer further
details, especially in HCM and LVNC.
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4.1. Pediatric Dilated Cardiomyopathy
All DCM studies reported reduced LVEF and abnormal LV strain values (longitudinal,
circumferential and radial), when compared to controls. Adult data supports the notion
that abnormal LV strain is predictive of cardiac events [6], and STE has been shown to
be a more sensitive tool in assessing changes in LV systolic function than LVEF alone in
children with other causes of LV dysfunction, such as anthracycline toxicity [40]. Thus,
it is reasonable to include measurements of LV strain in the diagnosis and follow-up of
pediatric DCM, in addition to conventional parameters. Two studies showed abnormal
rotation [22] and dys-synchrony parameters [24], but their clinical significance has not yet
been established.
4.2. Pediatric Hypertrophic Cardiomyopathy
All HCM studies reported normal/supranormal LVEF, with one reporting abnormal
E/E’. Just two studies reported LV deformation parameters: normal Sc (less negative in
apical segments) in one [28] and abnormal Sl in the second [21]. Both studies reporting
rotational mechanics showed that basal rotation was less pronounced, while apical rotation
was increased compared to controls, also observed in adults with HCM [41], but not the
apical form, where apical rotation is reduced [42]. Rotational mechanics are thus a potential
tool for HCM screening in children, and a promising avenue for research. Both Pieles
et al. [29] and Forsey et al. [28] linked STE parameters to genotype variants, proposing a
role of STE in screening and risk stratification. As opposed to adult HCM, where LV systolic
deformation is reduced more frequently, [5] in children this was not seen consistently.
4.3. Left Ventricular Non-Compaction Cardiomyopathy
LV longitudinal, circumferential and radial strain were found to be abnormal com-
pared to controls, as well as apical rotation, and subsequently twist and torsion. Basal
rotation was normal, as opposed to adults, where decreased basal rotation was reported,
in addition to rigid body rotation [7]. These findings support the notion that changes in
myocardial mechanics are seen as early as childhood, and progress through adulthood,
making STE a very useful tool for follow-up and screening.
4.4. Arrhythmogenic Cardiomyopathy
ACM was only reported in one cohort, despite growing evidence that early pediatric
cases pose significant issues in early diagnosis, follow-up and risk stratification [4,43].
Recent adult data from the Dutch ACM Registry also showed that myocardial mechanics
are altered in gene carriers not meeting diagnosis criteria, as well as an early potential sign
of disease progression [12,13]. Nevertheless, given the importance of early ACM diagnosis
to prevent sudden cardiac death, more research is needed to determine whether STE can
accurately identify children with ACM.
4.5. Current Issues and Future Directions
We found few studies reported similar STE measurements in the same inherited
cardiomyopathy type (three at most or any parameter in the same disease), highlighting
the urgent need for a standardized protocol for children. This is further emphasized by the
overall high risk of bias observed (only 3/14 of studies achieved a low risk), which may
not reflect poor study quality, but rather inherent limitations in reporting, compounded
by heterogeneous center practices. Nevertheless, most STE parameters were found to be
altered in inherited cardiomyopathies when compared to healthy controls, even when
reported as secondary findings.
From a clinical point of view, the data summarized by this systematic review suggest
that, while it is reasonable to report longitudinal strain alongside conventional systolic
function parameters, there is a stringent need for prospective, longitudinal studies in
pediatric ICCs, to determine the exact benefits of adding STE to the standard of care. In ad-
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dition, more data are needed to establish the role of rotational mechanics and dyssynchrony
parameters in clinical practice.
4.6. Limitations
The main limitation comes from the small number of studies included, with very
different populations and measurements, limiting the report to a synthesis without meta-
analysis. All included studies had inherent patient selection biases, and this extends
to our analysis. In addition, studies with negative results tend not to be reported, and
this can cause publishing bias. Inter-vendor variability of STE measurements between
studies was expected [44], and for this reason standardized mean differences were used in
comparisons, instead of reported values. The analysis was also limited in its scope, with at
most three cohorts reporting the same measurement in the same condition. Some items
in the Newcastle-Ottawa scale for case-control studies were difficult to address in most
imaging studies, due to inherent methodological flaws (e.g., impossibility of true blinding,
tendency to select controls from healthy hospital patients), and, as such, the risk of bias
could have been over-estimated. To balance this, we also used a semi-qualitative grading
of studies (low/medium/high), taking scale results into consideration. Studies reporting
cardiomyopathies secondary to other pathology have not been included, to try to minimize
diagnostic heterogeneity. However, we acknowledge that in the studies included, some
diagnostic misclassification may have occurred.
5. Conclusions
There is limited data on STE use in pediatric inherited cardiomyopathy, especially
in ACM, with significant variety in reported STE measurements. The available data
indicates that there are early changes during childhood measurable by STE, with or without
abnormal ventricular systolic or diastolic function by non-STE methods. Longitudinal
and circumferential strain should be introduced in the cardiomyopathy echocardiography
protocol, mirroring adult practice. Myocardial mechanics, especially rotational parameters
in LVNC and HCM show promise as early screening tools, and should be used when the
expertise is available.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/diagnostics11040635/s1, Supplementary Materials—Search Strategy, Additional Method-
ological Data, Table S1—Summary of cardiac function by non-speckle tracking measurements, Table
S2—Summary of cardiac function and mechanics by speckle tracking measurements.
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